Publications by authors named "E F Shepherd"

Bovine respiratory disease (BRD) is one of the most common economic and health challenges to the beef cattle industry. Prophylactic use of antimicrobial drugs can alter the microbial communities in the respiratory tract. Considering that the bovine upper respiratory tract microbiome has been associated with generalized health, understanding the microenvironment that influences this microbiome may provide insights into the pathogenesis of BRD.

View Article and Find Full Text PDF

We assessed the use of magnesium sulphate prior to preterm birth for preventing cerebral palsy in an Australian and New Zealand registry study. Use increased markedly from 32.3% (2012) to 78.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates risk factors for proliferative vitreoretinopathy (PVR), a common complication after retinal detachment surgery.
  • A large patient database was analyzed, identifying systemic (like age, gender, and smoking) and ocular (such as trauma and previous eye conditions) factors that correlate with increased PVR risk.
  • The findings emphasize the importance of considering these risk factors in surgical planning and treatment to prevent PVR in patients with retinal detachment.
View Article and Find Full Text PDF
Article Synopsis
  • * A new technique called polymerase error rate sequencing (PER-seq) was developed to measure DNA polymerase error rates, revealing that a common Pol ε mutant (P286R) significantly increases CpG>TpG errors similar to those seen in cancer tumors.
  • * Wild-type Pol ε shows a much higher error rate when replicating 5mCpG as opposed to regular cytosines, indicating that replication errors represent a crucial factor in CpG>TpG mutagenesis and altering the
View Article and Find Full Text PDF
Article Synopsis
  • Gremlin-1 has been linked to liver fibrosis in metabolic dysfunction-associated steatohepatitis (MASH) by inhibiting BMP signaling, making it a potential focus for therapy.* -
  • In studies using rat and human models, blocking Gremlin-1 with antibodies did not reduce liver inflammation or fibrosis, despite its increased presence in specific myofibroblast cells.* -
  • Findings indicate that Gremlin-1 does not significantly contribute to liver fibrosis development and is not a viable target for treatment due to its limited role in the disease process.*
View Article and Find Full Text PDF